Skip to main content
2025 CRT Conference Main banner
Back

CRT 2025

Evening Symposium

Panel Discussion

Sunday, March 9, 2025
7:40 PM – 7:50 PM ET

    Panel Moderator(s)

  • Marc Cohen, MD

    Chair of Medicine
    Newark Beth Israel Med Ctr
    Philadelphia, Pennsylvania, United States

    Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Daiichi Sankyo, Boeringer Ingelheim , Sanofi, AstraZeneca , Chiesi, Bracco, Amgen, Novo Nordisk, Philips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • C. Michael Gibson, MD

    Professor of Medicine
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States

    Disclosure information not submitted.

  • Neal S. Kleiman, MD, FACC, MSCAI

    Medical Director, Cardiac Catheterization Laboratories
    Houston Methodist DeBakey Heart and Vascular Center
    Houston, Texas, United States

    Disclosure information not submitted.

    • Panel Discussant(s)

  • Usman Baber, MD, MS

    Professor of Medicine
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma, United States

    Disclosure information not submitted.

  • Colin Barker, Sr., MD

    Director
    VUMC
    Nashville, Tennessee, United States

    Disclosure(s): No financial relationships to disclose

  • Ankur Kalra, MD

    Interventional Cardiologist
    Franciscan Health, United States

    Disclosure(s): No financial relationships to disclose

  • AK

    Ajar Kochar, MD, MHS

    Program Director
    Brigham and Women's Hospital/Harvard Medical School
    CHESTNUT HILL, Massachusetts, United States

    Disclosure(s): Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); American Heart Association: Grant/Research Support (Ongoing); Faraday Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Rampart Medical: Grant/Research Support (Ongoing); Shockwave Inc: Grant/Research Support (Ongoing)

  • MP

    Megha Prasad, MD

    Assistant professor
    Columbia university

    Disclosure information not submitted.

  • Srihari S. Naidu, MD, FSCAI

    Director, Cath Labs and HCM Program
    Westchester Medical Center
    Valhalla, New York, United States

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Marc Cohen, MD: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Daiichi Sankyo, Boeringer Ingelheim , Sanofi, AstraZeneca , Chiesi, Bracco, Amgen, Novo Nordisk, Philips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Colin Barker, MD, Sr.: No financial relationships to disclose
Ankur Kalra, MD: No financial relationships to disclose
Ajar Kochar, MD, MHS: Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); American Heart Association: Grant/Research Support (Ongoing); Faraday Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Rampart Medical: Grant/Research Support (Ongoing); Shockwave Inc: Grant/Research Support (Ongoing)
Srihari S. Naidu, MD, FSCAI: No financial relationships to disclose